PerkinElmer Receives FDA Clearance for Lysosomal Storage Disorder Test
NeoLSD™ MSMS Kit is First Commercial IVD Kit to Use Mass Spectrometry to Screen for Six LSDs in Newborn Babies from a Single Dried Blood Spot Sample WHAT: PerkinElmer, Inc., a global leader in innovating for a healthier world, today announced that it received 510(k) clearance from the FDA to commercially market its NeoLSD™ MSMS... Read more